News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
494,543 Results
Type
Article (33791)
Company Profile (329)
Press Release (460414)
Multimedia
Podcasts (110)
Webinars (16)
Section
Business (137010)
Career Advice (2608)
Deals (25262)
Drug Delivery (110)
Drug Development (66534)
Employer Resources (160)
FDA (10937)
Job Trends (11363)
News (242604)
Policy (23713)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2099)
Accelerated approval (31)
Adcomms (22)
Allergies (119)
Alliances (35179)
ALS (153)
Alzheimer's disease (1451)
Antibody-drug conjugate (ADC) (296)
Approvals (11156)
Artificial intelligence (420)
Autoimmune disease (136)
Automation (26)
Bankruptcy (239)
Best Places to Work (9246)
BIOSECURE Act (19)
Biosimilars (150)
Biotechnology (252)
Bladder cancer (134)
Brain cancer (54)
Breast cancer (555)
Cancer (4182)
Cardiovascular disease (347)
Career advice (2209)
Career pathing (39)
CAR-T (267)
CDC (40)
Cell therapy (695)
Cervical cancer (27)
Clinical research (56840)
Collaboration (1493)
Company closure (3)
Compensation (674)
Complete response letters (49)
COVID-19 (2373)
CRISPR (92)
C-suite (710)
Cystic fibrosis (143)
Data (5519)
Decentralized trials (2)
Denatured (25)
Depression (117)
Diabetes (409)
Diagnostics (4407)
Digital health (29)
Diversity (8)
Diversity, equity & inclusion (34)
Drug discovery (238)
Drug pricing (191)
Drug shortages (20)
Duchenne muscular dystrophy (225)
Earnings (56041)
Editorial (62)
Employer branding (21)
Employer resources (142)
Events (77484)
Executive appointments (821)
FDA (13552)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (24)
Funding (1278)
Gene editing (200)
Generative AI (39)
Gene therapy (575)
GLP-1 (849)
Government (4185)
Grass and pollen (3)
Guidances (354)
Healthcare (14543)
HIV (49)
Huntington's disease (46)
IgA nephropathy (80)
Immunology and inflammation (228)
Immuno-oncology (48)
Indications (86)
Infectious disease (2588)
Inflammatory bowel disease (175)
Inflation Reduction Act (16)
Influenza (90)
Intellectual property (212)
Interviews (522)
IPO (13071)
IRA (55)
Job creations (2438)
Job search strategy (1793)
JPM (62)
Kidney cancer (11)
Labor market (72)
Layoffs (486)
Leadership (35)
Legal (4793)
Liver cancer (66)
Longevity (13)
Lung cancer (570)
Lymphoma (328)
Machine learning (36)
Management (58)
Manufacturing (652)
MASH (157)
Medical device (8583)
Medtech (8621)
Mergers & acquisitions (13109)
Metabolic disorders (1108)
Multiple sclerosis (135)
NASH (17)
Neurodegenerative disease (289)
Neuropsychiatric disorders (84)
Neuroscience (2579)
Neurotech (1)
NextGen: Class of 2026 (5068)
Non-profit (3613)
Now hiring (39)
Obesity (520)
Opinion (305)
Ovarian cancer (157)
Pain (162)
Pancreatic cancer (198)
Parkinson's disease (276)
Partnered (28)
Patents (386)
Patient recruitment (419)
Peanut (50)
People (42398)
Pharmaceutical (52)
Pharmacy benefit managers (22)
Phase 1 (18513)
Phase 2 (25460)
Phase 3 (18428)
Pipeline (4475)
Policy (281)
Postmarket research (1590)
Preclinical (7722)
Press Release (40)
Prostate cancer (206)
Psychedelics (53)
Radiopharmaceuticals (277)
Rare diseases (808)
Real estate (3658)
Recruiting (71)
Regulatory (18432)
Reports (33)
Research institute (1960)
Resumes & cover letters (406)
Rett syndrome (28)
RNA editing (21)
RSV (54)
Schizophrenia (136)
Series A (214)
Series B (166)
Service/supplier (2)
Sickle cell disease (98)
Special edition (24)
Spinal muscular atrophy (144)
Sponsored (32)
Startups (2847)
State (2)
Stomach cancer (8)
Supply chain (79)
Tariffs (83)
The Weekly (84)
Vaccines (849)
Venture capital (90)
Weight loss (327)
Women's health (66)
Worklife (22)
Date
Today (6)
Last 7 days (477)
Last 30 days (1804)
Last 365 days (25024)
2026 (2307)
2025 (25356)
2024 (29120)
2023 (32767)
2022 (41110)
2021 (44524)
2020 (42168)
2019 (35157)
2018 (26629)
2017 (24189)
2016 (22330)
2015 (26145)
2014 (19023)
2013 (14511)
2012 (15363)
2011 (16044)
2010 (14198)
Location
Africa (724)
Alabama (74)
Alaska (7)
Arizona (164)
Arkansas (9)
Asia (30368)
Australia (5271)
California (9039)
Canada (2702)
China (971)
Colorado (357)
Connecticut (381)
Delaware (307)
Europe (65203)
Florida (1332)
Georgia (292)
Hawaii (3)
Idaho (35)
Illinois (676)
India (48)
Indiana (340)
Iowa (14)
Japan (343)
Kansas (100)
Kentucky (24)
Louisiana (20)
Maine (54)
Maryland (1100)
Massachusetts (6885)
Michigan (248)
Minnesota (437)
Mississippi (4)
Missouri (76)
Montana (26)
Nebraska (14)
Nevada (91)
New Hampshire (62)
New Jersey (2566)
New Mexico (20)
New York (2396)
North Carolina (1124)
North Dakota (7)
Northern California (4351)
Ohio (261)
Oklahoma (13)
Oregon (32)
Pennsylvania (1775)
Puerto Rico (22)
Rhode Island (30)
South America (930)
South Carolina (56)
Southern California (3616)
Tennessee (106)
Texas (1393)
United States (32197)
Utah (196)
Vermont (1)
Virginia (219)
Washington D.C. (62)
Washington State (807)
West Virginia (2)
Wisconsin (80)
Wyoming (2)
494,543 Results for "go therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Janux Therapeutics Appoints William Go, M.D., Ph.D., as Chief Medical Officer
January 27, 2026
·
6 min read
China
Clinical Trials Are Increasingly Going Global—With China a Main Beneficiary
AstraZeneca’s $15 billion pledge to its China operations highlights the country’s advantages. But other regions are also hoping to host more clinical studies.
February 2, 2026
·
8 min read
·
Annalee Armstrong
Earnings
Roche Plans To Go Toe-to-Toe With Novo, Lilly in Obesity
Roche aims to become a “top three player” in obesity, Teresa Graham, CEO of the group’s Pharma unit, said Thursday during a presentation of the company’s full-year 2025 earnings.
January 29, 2026
·
2 min read
Career Advice
Going With the Flow: Finding Success in Academic and Biotech Research Cultures
At some point in your research career, you may find yourself transitioning from academia to industry or vice versa. To best set yourself up for success, adapt your approach to the specific scientific culture where you work.
January 21, 2026
·
6 min read
·
Manali Shah
Press Releases
Medtronic Diabetes announces FDA clearance for MiniMed Go™ Smart MDI system featuring Instinct sensor made by Abbott
January 13, 2026
·
6 min read
Press Releases
LakeShore Biopharma Enters into Definitive Agreement for Going-Private Transaction
November 5, 2025
·
7 min read
Cell and Gene Therapy
FDA’s New Cell and Gene Therapy Guidances Finally Go a ‘Click Further’ to ‘Game Changing’
Following up on previous, dimly received issuances, a new set of ideas published by the FDA to streamline regulatory pathways for cell and gene therapies ‘for small populations’ is receiving a warmer welcome—but experts warn it will take more to turn the tide for the fraught therapeutic space.
October 3, 2025
·
5 min read
·
Dan Samorodnitsky
Bankruptcy
Bluebird’s Go-Private Deal Highlights Fraught Life Preserver for Struggling Biotechs
Facing declining valuations and funding challenges, public biotechs like bluebird bio are going private to restructure, reduce regulatory burdens and refocus on long-term growth.
March 12, 2025
·
6 min read
·
Ana Mulero
Press Releases
Matica Biotechnology Emerges as the Go-To CDMO for Cell & Gene Therapy in 2025
October 7, 2025
·
2 min read
Funding
Novo Foundation Pumps $850M Into Denmark, Europe to Bolster Innovation
The Novo Nordisk Foundation’s funds will go toward supporting early-stage companies working in “human health, planetary health and societal resilience.”
January 16, 2026
·
2 min read
·
Tristan Manalac
1 of 49,455
Next
